Literature DB >> 6218781

Comparison of cefoperazone and cefoxitin concentrations in serum and pelvic tissue of abdominal hysterectomy patients.

R E Bawdon, D L Hemsell, S P Guss.   

Abstract

Cefoperazone and cefoxitin concentrations were determined in serum and pelvic tissue samples obtained at various intervals after a 2-g intramuscular dose. These levels were determined in 59 women scheduled for elective abdominal hysterectomy. Concentrations were measured by a new high-pressure liquid chromatography method which correlated with the microbiological assay. The mean times (+/- standard deviation) of specimen collection were 188.5 +/- 61 and 185.5 +/- 55 min for cefoperazone and cefoxitin, respectively. The mean serum levels (+/- standard deviation) were 60.8 +/- 18.0 and 14.6 +/- 8.6 micrograms/ml, respectively. For cefoperazone, the mean pelvic tissue concentration was 19.8 micrograms/g. The mean pelvic tissue concentration for cefoxitin was 7.8 micrograms/g. The ratio of tissue concentration to serum concentration varied from 0.220 to 0.469 for cefoperazone and from 0.176 to 1.031 for cefoxitin. Although the serum and tissue concentrations of cefoperazone were much higher than those of cefoxitin, a greater portion of cefoxitin remained in the tissue. The tissue levels of both cefoperazone and cefoxitin were above the minimum inhibitory concentration of most sensitive pathogens several hours after a single prophylactic dose of either antibiotic.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218781      PMCID: PMC185709          DOI: 10.1128/AAC.22.6.999

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Pelvic tissue and serum concentrations of various antibiotics given as pre-operative medication.

Authors:  M G Elder; M J Bywater; D S Reeves
Journal:  Br J Obstet Gynaecol       Date:  1977-12

2.  Maternal and fetal pharmacokinetics of moxalactam given intrapartum.

Authors:  R E Bawdon; F G Cunningham; J G Quirk; M L Roark
Journal:  Am J Obstet Gynecol       Date:  1982-11-01       Impact factor: 8.661

3.  Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.

Authors:  T O Kurtz; D J Winston; J A Hindler; L S Young; W L Hewitt; W J Martin
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

4.  Antibiotic prophylaxis for abdominal hysterectomy.

Authors:  P Duff
Journal:  Obstet Gynecol       Date:  1982-07       Impact factor: 7.661

5.  Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

6.  Cefoxitin serum and uterine concentrations following a two-gram intramuscular dose.

Authors:  D L Hemsell; I Birkett; L Reveley; J A Bland
Journal:  Obstet Gynecol       Date:  1982-02       Impact factor: 7.661

7.  Pharmacokinetics of intramuscular ceforanide in infants, children, and adolescents.

Authors:  A S Dajani; M C Thirumoorthi; R E Bawdon; J A Buckley; M Pfeffer; D R Van Harken; R D Smyth
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

8.  Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria.

Authors:  M W Drulak; A W Chow
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

9.  Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections.

Authors:  R L Sweet; W J Ledger
Journal:  Obstet Gynecol       Date:  1979-08       Impact factor: 7.661

  9 in total
  6 in total

1.  Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.

Authors:  J A Bosso; R A Prince
Journal:  Tex Heart Inst J       Date:  1990

2.  High-pressure liquid chromatographic assay of sulbactam in plasma, urine, and tissue.

Authors:  R E Bawdon; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

3.  Pharmacokinetic disposition and bactericidal activities of cefepime, ceftazidime, and cefoperazone in serum and blister fluid.

Authors:  D Kalman; S L Barriere; B L Johnson
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

4.  Pharmacokinetics of cefoperazone in ambulatory elderly volunteers compared with young adults.

Authors:  B R Meyers; M H Mendelson; R G Deeter; E Srulevitch-Chin; M T Sarni; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

5.  Serum and blister fluid pharmacokinetics and bactericidal activities of ampicillin-sulbactam, cefotetan, cefoxitin, ceftizoxime, and ticarcillin-clavulanate.

Authors:  G S Jaresko; S L Barriere; B L Johnson
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

Review 6.  Selection of appropriate analytical tools to determine the potency and bioactivity of antibiotics and antibiotic resistance.

Authors:  Nishant A Dafale; Uttam P Semwal; Rupak K Rajput; G N Singh
Journal:  J Pharm Anal       Date:  2016-05-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.